zinc oxide has been researched along with Colitis, Ulcerative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Chai, Z; Chen, H; Feng, W; Li, J; Wang, B; Yang, X | 1 |
1 other study(ies) available for zinc oxide and Colitis, Ulcerative
| Article | Year |
|---|---|
ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Homeostasis; Mice; Nanoparticles; NF-E2-Related Factor 2; Signal Transduction; Treatment Outcome; Zinc Oxide | 2017 |